To include your compound in the COVID-19 Resource Center, submit it here.

OvaRex MAb: Phase II comparability data; Phase III

In a U.S. Phase II study in 26 patients, OvaRex derived from mouse ascites fluid

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE